Nectar Lifesciences Ltd
BSE:532649
Nectar Lifesciences Ltd
BSE:532649
Price:
10.51
INR
-0.47%
Market Closed
Market Cap:
₹2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nectar Lifesciences Ltd
BSE:532649
|
IN |
|
B
|
Benchmark Electronics Inc
XMUN:BMU
|
US |
|
A
|
Asia Plus Group Holdings PCL
SET:ASP
|
TH |
|
A
|
Advanced Micro Devices Inc
F:AMD
|
US |
|
C
|
Cochlear Ltd
F:OC5
|
AU |
|
F
|
Fresenius SE & Co KGaA
F:FRE
|
DE |
|
P
|
Pharol SGPS SA
XMUN:PTCA
|
PT |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NECLIFE's stock price target?
Not Available
NECLIFE does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nectar Lifesciences Ltd?
Projected CAGR
139%
139%
Over the last 14 years, the compound annual growth rate for Revenue has been -37%. The projected CAGR for the next 8 years is 139%.
What is the Gross Profit forecast for Nectar Lifesciences Ltd?
Projected CAGR
71%
71%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -30%. The projected CAGR for the next 8 years is 71%.
